Biocom, Octane Form Strategic Partnership to Accelerate Medical Innovation

Biocom and Octane have announced a strategic partnership to expand access to capital, accelerator programs, and industry networks for California life science and medtech companies and key life science ecosystems.

Through the partnership, Biocom will extend the reach of its global life science membership network into Orange County while connecting Octane’s innovation network to life science leaders in California, nationally, and internationally. Octane will expand access to its accelerator programs, investor networks, and growth platform more broadly to companies across the Biocom community, giving emerging and growth-stage companies a single, coordinated path to resources, capital, and markets.

“Biocom and Octane each bring unique strengths to the life science and medtech innovation ecosystems,” Biocom CEO Tim Scott said. “By bringing together Octane’s accelerator and investor networks with Biocom’s life science community, we are creating new pathways for entrepreneurs to access capital, partnerships, and growth opportunities.”

Expanding Opportunities for Life Science, Medtech Companies

The Biocom-Octane collaboration aims to expand access to growth resources, industry events, and investment opportunities for life sciences and medtech companies. Firms participating in Octane’s LaunchPad accelerator will receive one year of complimentary Biocom membership, providing access to policy and advocacy, workforce development initiatives, cost-saving Biocom Group Purchasing programs, and the Biocom Health Benefits Trust.

Biocom members will gain greater exposure to Octane’s innovation community through its industry conferences, capital programs, and investor network, with preferred pricing for Octane events and opportunities to engage with its network of entrepreneurs, investors, and corporate partners. Octane will work closely with Biocom to identify high-potential life science and medtech companies within the Biocom membership and help prepare them for fundraising, strategic partnerships, and growth.

“Octane and Biocom share a common mission: to help innovative companies start, grow and scale,” Octane CEO Bill Carpou stated. “Octane’s track record of guiding companies from concept to commercialization, combined with Biocom’s industry influence and connectivity, will accelerate the development and deployment of new life science and medtech technologies.”

The organizations will also work together to promote industry programs, support emerging companies and strengthen connections across California and other major innovation hubs, including San Diego, Orange County, Greater Los Angeles, the Bay Area, Boston, and Washington state, creating a more connected and efficient pipeline from innovation to commercialization.

Biocom represents more than 1,700 member companies and organizations across the life science industry, while Octane’s portfolio companies have collectively raised more than $12.1 billion in capital since 2010. Together, the organizations can provide a combination of market access, advocacy, accelerator expertise, and investor networks to companies at every stage of growth.

By leveraging their combined networks and expertise, the organizations aim to speed the development and commercialization of breakthrough technologies while helping companies overcome barriers to capital, talent, and market adoption. Biocom and Octane will remain independent organizations operating under their respective brands and leadership while collaborating on programs, membership engagement, and strategic initiatives that reinforce California’s leadership in life science and technology innovation.

Biocom is the largest life science membership association, representing companies in California and major life science markets worldwide. Founded in 1995, Biocom works to drive innovation and industry competitiveness across the life science ecosystem. Its community includes biotechnology, pharmaceutical, medical device, genomics, and diagnostics companies at every stage, as well as research institutions, investors, service providers, and emerging technology innovators. Biocom works on behalf of its members to build connections and deliver valuable insights through conferences and events, expand access to funding and partnering opportunities, provide group purchasing solutions that drive efficiency and savings, champion policy and advocacy that protects and advances innovation, and strengthen talent pipelines through workforce development.

Biocom maintains offices in San Diego, Los Angeles, and the San Francisco Bay Area, with satellite offices in Sacramento, Washington, D.C., and Tokyo, and a growing presence in Seattle, bridging regional ecosystems and global markets to strengthen growth.

Octane is an accelerator and innovation organization headquartered in Newport Beach, Calif., that helps technology and medtech companies start, grow, and scale. Through its LaunchPad accelerator, capital programs, and industry forums, Octane connects entrepreneurs with investors, corporate partners, and strategic resources to accelerate company growth and drive successful commercialization outcomes. Octane acts as a platform that brings together entrepreneurs, investors, corporations, universities, and healthcare systems to help startups scale faster.